D
Centessa Pharmaceuticals plc CNTA
$11.80 -$1.26-9.65%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings CNTA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating D
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors CNTA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Very Weak
Efficiency Index Very Weak
Solvency Index Excellent
Total Return Index Fair
Volatility Index Weak
Beta / Standard Deviation CNTA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 1.34
Price History CNTA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -18.84%
30-Day Total Return -29.04%
60-Day Total Return -31.87%
90-Day Total Return -35.13%
Year to Date Total Return -32.57%
1-Year Total Return 13.79%
2-Year Total Return 212.17%
3-Year Total Return 19.80%
5-Year Total Return --
52-Week High % Change -31.59%
52-Week Low % Change 68.52%
Price CNTA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $19.09
52-Week Low Price $7.75
52-Week Low Price (Date) May 29, 2024
52-Week High Price (Date) Feb 07, 2025
Valuation CNTA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 1.74B
Enterprise Value 1.38B
Price/Earnings (TTM) --
Earnings Per Share (TTM) -1.99
Earnings Per Share Growth 26.63%
Price/Earnings To Growth --
Price/Sales (TTM) --
Price/Book (Q) 4.31
Enterprise Value/Revenue (TTM) --
Price $11.80
Enterprise Value/EBITDA (TTM) -6.85
Enterprise Value/EBIT -6.84
Market Cap Category Small Cap
Dividends and Shares CNTA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 132.05M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info CNTA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number --
Address --
Website www.centessa.com
Country United Kingdom
Year Founded 2020
Profitability CNTA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) --
Profit Margin --
Management Effectiveness CNTA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -26.82%
Return on Equity --
Income Statement CNTA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) --
Total Revenue (TTM) --
Revenue Per Share --
Gross Profit (TTM) --
EBITDA (TTM) -200.71M
EBIT (TTM) -201.06M
Net Income (TTM) -235.76M
Net Income Avl. to Common (TTM) -235.76M
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) -202.22%
EPS Diluted (TTM) -1.99
EPS Diluted Growth (Q YOY) -124.11%
Balance Sheet CNTA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 482.18M
Cash Per Share (Q) $3.65
Total Current Assets (Q) 536.41M
Total Preferred Equity (Q) --
Total Equity (Q) 401.55M
Current Ratio (Q) 9.249
Book Value Per Share (Q) $3.03
Total Assets (Q) 576.80M
Total Current Liabilities (Q) 58.00M
Total Debt (Q) 117.83M
Total Liabilities (Q) 175.25M
Total Common Equity (Q) 401.55M
Cash Flow CNTA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) 31.27M
Cash from Financing (TTM) 364.75M
Net Change in Cash (TTM) 255.19M
Levered Free Cash Flow (TTM) -74.68M
Cash from Operations (TTM) -142.06M
Weiss Ratings